ArticleJournal of cardiothoracic surgery2025
A two-sample Mendelian randomization study of atrial fibrillation screening, risk factor analysis, and serum uric acid levels.
Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt aimed to explore the relationship between atrial fibrillation (AF) screening, risk factor analysis, and serum uric acid (UA) levels. By analyzing the results of AF screening and risk factors, the potential impact of serum UA levels on AF risk was further investigated.
methodsThe study population consisted of 979 patients who underwent physical examinations between January 2023 to October 2023, and were divided into two groups based on AF screening results: the AF screening group (n = 490) and the routine examination group (n = 489). The AF screening group underwent AF screening, risk factor analysis, and measurement of serum UA levels, while the routine examination group only received AF screening and routine health check-ups. Utilizing the Global Urate Genetics Consortium (GUGC) dataset, 28 single nucleotide polymorphisms (SNPs) associated with serum UA levels were identified and applied in a Mendelian randomization (MR) study to assess the causal relationship between serum UA levels and AF.
resultsApart from gender, the general data of the experimental and control groups were similar. In patients aged 50-59 and over 70 years, the detection rate of AF in males was significantly higher than that in females (P < 0.05). After adjusting for age and gender, hyperlipidemia, stroke, hyperuricemia, and hyperthyroidism were identified as risk factors for AF. Multivariate logistic regression analysis showed a significant association between elevated serum UA levels and increased AF risk. Further analysis indicated a clear dose-response relationship between serum UA levels and AF risk (P < 0.05), suggesting a potential causal effect of serum UA levels on AF risk.
conclusionThis article demonstrated a significant dose-response relationship between elevated serum UA levels and AF risk, further supporting serum UA as an independent risk factor for AF. Moreover, through MR analysis, the potential causal relationship between serum UA levels and AF was validated, providing a new perspective and basis for AF screening and early diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.